bk tirzepatide Hush Medical Spa Tirzepatide's Association With BP Reduction

Hims LifeMD and Hims are both well-known names in telehealth, and now theyve expanded into weight loss but they take different approaches

The enrollment process is described as simple and private

In the SURMOUNT-1 trial, tirzepatide achieved up to 22.5% body weight reduction over 72 weeks, compared to roughly 17% with semaglutide in similar studies

Foundayo: New Oral GLP-1 Option (April 2026) Oral Alternative Now Available Foundayo (orforglipron) is Eli Lilly's new oral GLP-1 medication, FDA-approved in April 2026

Your genetics also play a role: variants in the GLP1R and GIPR genes influence how quickly your body responds and adapts to peptide signaling

Strengths More effective than semaglutide in most patients